Popular stomach acid reducer triples risk of developing...( WINSTON-SALEM N.C. A popular stomac...),Health
WINSTON-SALEM, N.C. A popular stomach-acid reducer used to prevent stress ulcers in critically ill patients needing breathing machine support increases the risk of those patients contracting pneumonia threefold, according to researchers at Wake Forest University School of Medicine.
Hospital-acquired pneumonia is the leading cause of infection-related deaths in critically ill patients. It increases hospital stays by an average of seven to nine days, cost of care, and the risk of other complications.
"As best we can tell, patients who develop hospital-acquired pneumonia or ventilator-acquired pneumonia have about a 20 to 30 percent chance of dying from that pneumonia," said senior study author David L. Bowton, M.D., professor and head of the Section on Critical Care in the Department of Anesthesiology. "It's a significant event."
The study, published in a recent issue of CHEST, compared treatment with two drugs that decrease stomach acid: ranitidine, marketed under the name ZantacTM, and pantoprazole, marketed under the name ProtonixTM or PrilosecTM.
Both drugs decrease stomach acid, but the newer pantoprazole is considered more powerful and has become the drug of choice in many hospitals.
However, in the analysis of 834 patient charts, the researchers found that hospitalized cardiothoracic surgery patients treated with pantoprazole were three times more likely to develop pneumonia.
"We conducted this study, in part, because we thought we were seeing more pneumonias than we were used to having," said study co-author Marc G. Reichert, Pharm.D., pharmacy coordinator for surgery at Wake Forest University Baptist Medical Center.
Both acid-reducing drugs can make the stomach a more hospitable place for bacteria to colonize. Patients on breathing machines sometimes develop pneumonia when stomach secretions reflux into the lungs.
Current treatment guidelines to prevent pneumonia recommend ra
'/>"/>
| Contact: Shannon Koontz shkoontz@wfubmc.edu 336-716-2415 Wake Forest University Baptist Medical Center Source:Eurekalert |
Related medicine news :
1. RZN Nutraceuticals Receives United States Patent & Trademark Office Notice of Allowance for Proprietary HerbaZorb(TM) Absorption and Delivery System Technology Used in Popular Arthri-Zen Relief(R) and Migra-Zen Relief PLUS(R) Products
2. Consumer Driven Health Plans Surpass HMOs in Popularity with Employees
3. Alternative Therapies And Their Growing Popularity
4. Consumer Driven Health Plans Surpass HMOs in Popularity With Employees
5. Nation's Most Popular Cosmetic Surgery Procedure is a Way for One Houston Plastic Surgeon to Renew Body Contours and Self-Esteem
6. Refurbished and Used Industrial Parts Washers Grow in Popularity
7. Popular Prescription Drug Discount Card Now Available in Arizona Online
8. New Survey Reveals High Expectations for Popular Aesthetic Injections
9. Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice-T
10. Popular Jellyfish Sting Treatment Also Proven Effective on Stings From Portuguese Man-of-War
11. PatientAssistance.com Releases the Top 20 Most Popular Searches for Patient Assistance Programs
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |